(Updated - March 16, 2023 3:23 AM EDT)

Oppenheimer analyst Matthew Biegler upgraded ORIC Pharamceuticals (NASDAQ: ORIC) from Perform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE